Gastric xanthelasma and metabolic disorders: A large retrospective study among Chinese population

Table 3 Metabolic comorbidities in xanthelasma and non-xanthelasma group n (%)

Metabolic comorbidity	Non-xanthelasma	Xanthelasma	P
Biliary and liver diseases
Chronic liver disease	2 (2.0)	4 (8.9)	0.911
Fatty liver	15 (15.2)	13 (28.9)	< 0.05
Hemangioma	1 (1.9)	1 (2.1)	0.568
Cyst	10 (10.1)	8 (17.0)	< 0.05
Post-cholecystectomy	2 (2.0)	4 (8.5)	0.911
Gallstone	4 (4.0)	3 (6.8)	0.132
Gallbladder polyp	9 (9.1)	3 (6.8)	< 0.01
Cardio-cerebral-vascular disease
Coronary artery disease	1 (1.0)	2 (4.9)	0.877
Atrial fibrillation	0 (0)	1 (2.4)	0.522
Carotid atherosclerosis	5 (5.1)	6 (14.6)	0.223
Stroke	0 (0)	1 (2.4)	0.522
Thyroid disease	4 (4.0)	4 (9.8)	0.187
Diabetes mellitus	1 (1.0)	2 (4.9)	0.877